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The cell wall glucans of yeasts and fungi consist of a linear backbone of -1,3-linked 
glucosylunits with -1,6-linked side chains (1). Although a lot is already known about the 
mechanism of action of -1,3/1,6-glucans on the innate immune system (2), there is still a lot to 
be learned about their effects on the adaptive immune system in mammals. We aimed to 
determine if oral supplementation could modulate a systemic immune response. The latter was 
examined in pigs using a model antigen. In three experiments using newly weaned pigs, 
Macrogard, a β-1,3/1,6-glucan from Saccharomyces cerevisiae, was administered in the feed 
during three different time periods (one, two and three weeks) and the adjuvant effect of this β-
glucan was determined on a systemic immunisation with thyroglobulin. A first immunisation 
occurred during β-glucan supplementation, while the second one occurred after ceasing the 
administration. Macrogard exerted significantly higher thyroglobulin-specific primary 
immunoglobulin (Ig) M and secondary IgA antibody responses in serum. However, Macrogard 
suppressed the thyroglobulin-specific proliferation of peripheral blood mononuclear cells. A 
higher dose of Macrogard significantly increased thyroglobulin-specific IgM but not IgA 
responses, and the animals itself showed hyperaemia. Suppression of the T-lymphocyte 
proliferation might account for the absence of the switch from IgM to IgA. Weight gain and feed 
conversion were also determined, without significant differences between groups. 
In conclusion, oral β-glucans are able to modulate the humoral as well as the cellular immunity 
against a systemically administered antigen. 
